Nov 12, 2019 · PULM closed up 26.73 percent on Wednesday, April 1, 2020, on 2.9 times normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Is There Now An Opportunity In Pulmatrix Inc (NASDAQ:PULM ... Mar 08, 2018 · Pulmatrix Inc (NASDAQ:PULM), a pharmaceuticals company based in United States, received a lot of attention from a substantial price movement on the NasdaqGM in the over the last few months, increasing to $1.99 at one point, and dropping to the lows of $1.39.This high level of volatility gives investors the opportunity to enter into the stock, and potentially buy at an artificially low price.

Is There Now An Opportunity In Pulmatrix Inc (NASDAQ:PULM ... Mar 08, 2018 · Pulmatrix Inc (NASDAQ:PULM), a pharmaceuticals company based in United States, received a lot of attention from a substantial price movement on the NasdaqGM in the over the last few months, increasing to $1.99 at one point, and dropping to the lows of $1.39.This high level of volatility gives investors the opportunity to enter into the stock, and potentially buy at an artificially low price. Two stocks I’d tuck away forever: Everi Holdings (EVRI ... Mar 10, 2020 · A Look At Pulmatrix (NASDAQ:PULM) With the previous 100-day trading volume average of 763141 shares, Pulmatrix (PULM) recorded a trading volume of 465880 shares, as the stock started the trading session at the value of $1.67, in the end touching the price of $1.47 after dropping by -11.98%. PULMATRIX INC : Stock Market News and Information ... LEXINGTON, Mass., Feb. 8, 2019 /PRNewswire/ -- Pulmatrix, Inc. ("Pulmatrix," the "Company," "we," "our" or "us") (NASDAQ: PULM) today announced that it has entered into a securities purchase agreement with certain institutional investors, providing for the purchase and sale of 1,706,484 shares of common stock at a price of $1.465 per share in a registered direct offering priced at-the-market

Pulmatrix, Inc. (PULM) Ownership Summary - NASDAQ.com

Find the latest analyst research for Pulmatrix, Inc. Common Stock (PULM) at Nasdaq.com. Pulmatrix Inc Stock Quote: PULM Stock News, Quotes ... Nov 08, 2019 · PULM, Pulmatrix Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines PULM Stock Price | Pulmatrix Inc. Stock Quote (U.S ... Pulmatrix Inc. Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products for respiratory and other diseases. Pulmatrix, Inc. Common Stock (PULM) Real-Time Stock Quote ...

MOMENTUMlooking at the price chart below; the technical indicators above Disease). http://ir.pulmatrix.com/Zacks-Initiates-on-Pulmatrix-NASDAQ-PULM

PULM Stock Price, Forecast & News (Pulmatrix) | MarketBeat

Pulmatrix, Inc. - PULM - Stock Price Today - Zacks

Dec 12, 2019 · Stock quote for Pulmatrix, Inc. Common Stock Common Stock (PULM) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. PULM - Pulmatrix Stock Technical Analysis - Barchart.com Technical Analysis Summary for Pulmatrix Inc with Moving Average, Stochastics, MACD, RSI, Average Volume.

See Pulmatrix, Inc. (PULM) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

$PULM Stock Technical Analysis | Pulmatrix, Inc ...

Historical index on US Stock Market : E "Should I invest in Pulmatrix stock?" "Should I trade "PULM" stock today?" According to our live Forecast System, Pulmatrix, Inc stock is a very good long-term (1-year) investment*. "PULM" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis.